Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Jan;16(1):63-70.
doi: 10.15252/embr.201439560. Epub 2014 Oct 31.

Direct interaction between Id1 and Zrf1 controls neural differentiation of embryonic stem cells

Affiliations

Direct interaction between Id1 and Zrf1 controls neural differentiation of embryonic stem cells

Luigi Aloia et al. EMBO Rep. 2015 Jan.

Abstract

Id proteins are dominant-negative regulators within the HLH family of proteins. In embryonic stem cells (ESCs), Id1 and Id3 maintain the pluripotent state by preventing neural differentiation. The Id1-interacting protein Zrf1 plays a crucial role as a chromatin-bound factor in specification of the neural fate from ESCs. Here, we show that Id1 blocks Zrf1 recruitment to chromatin, thus preventing the activation of neural genes in ESCs. Upon differentiation, Id1 expression decreases thus inducing Zrf1 binding to neural genes. Importantly, depletion of Zrf1 rescues the expression of Polycomb targets involved in neural specification which are up-regulated in Id1 knock-out ESCs. We therefore identified Zrf1 as transcriptional regulator of neural fate downstream of Id1 in ESCs.

Keywords: Id1; Polycomb; epigenetics; neural development.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Id1 overexpression impairs Zrf1 recruitment to chromatin during neural differentiation of ESCs
  1. ESCs were grown in either self-renewal conditions (serum plus LIF) or differentiation conditions (knock-out serum replacement, KSR, plus retinoic acid, RA). Extracts were subjected to immunoprecipitation with an antibody against either Zrf1 or Id1. Levels of co-immunoprecipitation of Id1 with Zrf1 (left), or of Zrf1 with Id1 (right), were assessed by Western blot.

  2. Zrf1 ChIPs were performed in ESCs transfected with an empty vector (Ctrl) or in Id1-Flag overexpressing ESCs. Zrf1-depleted ESCs were used as a control. Values are reported as percentage of input. Standard deviation (SD) is representative of three independent experiments. *< 0.05 and **< 0.01 (paired t-test) represent comparison with control ESCs at the corresponding time point.

  3. mRNA fold-change of Zrf1 targets under differentiation conditions (24 h RA). SD is representative of three independent experiments. *< 0.05; **< 0.01 (paired t-test).

Figure 2
Figure 2. Zrf1 overexpression rescues the expression of neural genes in Id1-overexpressing ESCs
  1. mRNA fold-changes of Id1, endogenous (mouse) and transgenic (human) Zrf1, pluripotent markers Cdh1 and Oct4, the neural markers Pax6, Sox1, Olig2, Hoxb1 and the epiblast/mesodermal marker T in control ESCs, Id1-Flag ESCs, or Id1-Flag ESCs transiently overexpressing Zrf1. Self-renewing conditions (day 0), and days 3 and 5 of neural differentiation were analyzed. SD is representative of three independent experiments. *< 0.05 and **< 0.01 (paired t-test) represent comparison with control ESCs at the corresponding time point.

  2. ChIP analysis for Zrf1 in control ESCs, Id1-Flag ESCs, and Id1-Flag ESCs transiently overexpressing Zrf1, grown in self-renewing conditions (day 0) and during neural differentiation (day 5). SD is representative of three independent experiments. Dashed line represents IgG background. **< 0.01 (paired t-test).

  3. Immunostaining of the neural progenitor marker Nestin and of the post-mitotic neuronal marker β3 tubulin in control ESCs, Id1-Flag ESCs, and Id1-Flag ESCs transiently overexpressing Zrf1 at day 5 of neural differentiation.

Figure 3
Figure 3. Zrf1 depletion restores expression of neural genes misregulated in Id1KO ESCs
  1. Gene ontology (GO) analysis of tissue expression of up- and down-regulated genes in Id1KO ESCs as compared to wild-type ESCs.

  2. Western blot analysis of Id1 and Zrf1 expression in wild-type and Id1KO ESCs upon Zrf1 depletion.

  3. Overlap between misregulated genes in Id1KO ESCs, genes significantly affected by Zrf1 depletion in Id1KO ESCs (identified by gene expression analysis), and Polycomb-bound genes in ESC (identified by ChIP-sequencing analysis).

  4. GO analysis of tissue expression of 642 genes identified as Polycomb targets misregulated in Id1KO ESCs, which are significantly affected by Zrf1 depletion.

  5. Heatmap analysis of Zrf1-regulated Polycomb genes whose expression is significantly enriched in brain and spinal cord.

  6. mRNA fold-changes of Otx2, Pax6, Sox4, and Sox11 in control ESCs, Id1KO ESCs, and Zrf1-depleted Id1KO ESCs. SD is representative of three independent experiments. **< 0.01 (paired t-test) represents comparison with Ctrl ESCs at the corresponding time point.

  7. Zrf1 ChIPs at Otx2, Pax6, Sox4, and Sox11 promoters in control ESCs, Id1KO ESCs, and Zrf1-depleted Id1KO ESCs. SD is representative of three independent experiments. **< 0.01 (paired t-test).

Figure 4
Figure 4. Zrf1 acts as transcriptional regulator of neural genes downstream of Id1
In wild-type ESCs, Id1 binds to Zrf1 and to other interactors (indicated as X). In self-renewing conditions, Id1 impairs Zrf1 binding to chromatin. Upon differentiation, Id1 expression decreases and Zrf1 is recruited to neural genes promoting their transcriptional activation by displacing Polycomb repressive complexes (PRC). Id1 overexpression blocks Zrf1 binding to chromatin, thus impairing the expression of neural genes during differentiation. In Id1KO ESCs, Zrf1 is bound on Polycomb target genes involved in neural differentiation, and promotes their expression. Correct expression of neural genes in Id1KO ESC is restored upon depletion of Zrf1.

References

    1. Niwa H. How is pluripotency determined and maintained? Development. 2007;134:635–646. - PubMed
    1. Ying QL, Nichols J, Chambers I, Smith A. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell self-renewal in collaboration with STAT3. Cell. 2003;115:281–292. - PubMed
    1. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 2003;13:410–418. - PubMed
    1. Lasorella A, Benezra R, Iavarone A. The ID proteins: master regulators of cancer stem cells and tumour aggressiveness. Nat Rev Cancer. 2014;14:77–91. - PubMed
    1. Norton JD. ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci. 2000;113(Pt 22):3897–3905. - PubMed

Publication types

MeSH terms

Associated data